dc.contributor.author
Lindner, Andreas K.
dc.contributor.author
Sarma, Navina
dc.contributor.author
Rust, Luise Marie
dc.contributor.author
Hellmund, Theresa
dc.contributor.author
Krasovski-Nikiforovs, Svetlana
dc.contributor.author
Wintel, Mia
dc.contributor.author
Klaes, Sarah M.
dc.contributor.author
Hoerig, Merle
dc.contributor.author
Monert, Sophia
dc.contributor.author
Schwarzer, Rolf
dc.contributor.author
Edelmann, Anke
dc.contributor.author
Martinez, Gabriela Equihua
dc.contributor.author
Mockenhaupt, Frank P.
dc.contributor.author
Kurth, Tobias
dc.contributor.author
Seybold, Joachim
dc.date.accessioned
2023-03-16T12:50:45Z
dc.date.available
2023-03-16T12:50:45Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/38420
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-38138
dc.description.abstract
Background: Living conditions in homeless shelters facilitate the transmission of COVID-19. Social determinants and pre-existing health conditions place homeless people at increased risk of severe disease. Described outbreaks in homeless shelters resulted in high proportions of infected residents and staff members. In addition to other infection prevention strategies, regular shelter-wide (universal) testing for COVID-19 may be valuable, depending on the level of community transmission and when resources permit.
Methods: This was a prospective feasibility cohort study to evaluate universal testing for COVID-19 at a homeless shelter with 106 beds in Berlin, Germany. Co-researchers were recruited from the shelter staff. A PCR analysis of saliva or self-collected nasal/oral swab was performed weekly over a period of 3 weeks in July 2020. Acceptability and implementation barriers were analyzed by process evaluation using mixed methods including evaluation sheets, focus group discussion and a structured questionnaire.
Results: Ninety-three out of 124 (75%) residents were approached to participate in the study. Fifty-one out of the 93 residents (54.8%) gave written informed consent; thus 41.1% (51 out of 124) of all residents were included in the study. Among these, high retention rates (88.9-93.6%) of a weekly respiratory specimen were reached, but repeated collection attempts, as well as assistance were required. Around 48 person-hours were necessary for the sample collection including the preparation of materials. A self-collected nasal/oral swab was considered easier and more hygienic to collect than a saliva specimen. No resident was tested positive by RT-PCR. Language barriers were the main reason for non-participation. Flexibility of sample collection schedules, the use of video and audio materials, and concise written information were the main recommendations of the co-researchers for future implementation.
Conclusions: Voluntary universal testing for COVID-19 is feasible in homeless shelters. Universal testing of high-risk facilities will require flexible approaches, considering the level of the community transmission, the available resources, and the local recommendations. Lack of human resources and laboratory capacity may be a major barrier for implementation of universal testing, requiring adapted approaches compared to standard individual testing. Assisted self-collection of specimens and barrier free communication may facilitate implementation in homeless shelters. Program planning must consider homeless people's needs and life situation, and guarantee confidentiality and autonomy.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Homelessness
en
dc.subject
Homeless shelter
en
dc.subject
Infection control
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Monitoring for COVID-19 by universal testing in a homeless shelter in Germany: a prospective feasibility cohort study
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
1241
dcterms.bibliographicCitation.doi
10.1186/s12879-021-06945-4
dcterms.bibliographicCitation.journaltitle
BMC Infectious Diseases
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.volume
21
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
34895157
dcterms.isPartOf.eissn
1471-2334